News from Janssen Therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

25 Oct, 2016, 08:00 ET Janssen Therapeutics Announces Funding in Support of Improved Retention in Care and Access to Treatment for Blacks and African Americans Living with HIV in Southern United States and other Rural Areas

Janssen Therapeutics* announced today the recipients of funding from a special Request for Applications (RFA) to encourage comprehensive...


18 Jul, 2016, 08:00 ET U.S. FDA Approves PREZISTA® (darunavir) for Use in Pregnant Women with HIV

 Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. Food and Drug Administration (FDA) has...


21 Mar, 2016, 17:00 ET Janssen Therapeutics Announces Funding for Organizations Focused on Improving Care and Treatment for Vulnerable Populations Living with HIV

 Janssen today announced the recipients of funding from two special Requests for Applications (RFA) to encourage innovative models of care and...


08 Sep, 2015, 08:00 ET Your Story, Your HIV Wisdom™ Brings Together HIV Voices and Supports HIV Community Organizations

Seeking and sharing information are important parts of the HIV journey – in fact, 80 percent of people living with HIV said they give advice...


05 Nov, 2014, 16:48 ET OLYSIO® (simeprevir) Gains Additional FDA Approval as Once-Daily, All-Oral Interferon- and Ribavirin-Free Treatment Option in Combination with Sofosbuvir for Adults with Genotype 1 Chronic Hepatitis C Infection

Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food and Drug Administration (FDA) has approved OLYSIO®...


25 Nov, 2013, 05:00 ET VIDEO NOW AVAILABLE: OLYSIO™ (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C

Janssen Therapeutics, Division of Janssen Products, LP (Janssen), announced today the U.S. Food and Drug Administration (FDA) has approved...


22 Nov, 2013, 20:25 ET OLYSIO™ (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C

 Janssen Therapeutics, Division of Janssen Products, LP (Janssen), announced today the U.S. Food and Drug Administration (FDA) has approved...


16 Jul, 2013, 08:30 ET Janssen Therapeutics Announces Recipient of Its Second Point Scholarship for LGBT Students

 Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced today the recipient of the second scholarship the company is...


30 May, 2013, 10:00 ET Survey of Participants from Landmark GRACE Trial Provides Patients' Perspectives from an HIV Clinical Study

 A survey of a segment of clinical trial participants from the GRACE (Gender, Race And Clinical Experience) trial, the largest-ever study of...


24 Apr, 2013, 08:06 ET Janssen Therapeutics LINCC™ Program Continues its Commitment to Underserved Populations with Charitable Contributions to 16 HIV/AIDS Organizations Across the U.S.

 Janssen Therapeutics, Division of Janssen Products, LP, today announced the 16 organizations that will receive a charitable contribution from...


31 Dec, 2012, 09:00 ET FDA Grants Accelerated Approval for SIRTURO™ (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis

Janssen Therapeutics, Division of Janssen Products, LP, today announced the U.S. Food and Drug Administration (FDA) has granted accelerated...


10 Dec, 2012, 16:01 ET FDA Approves Prescribing Information Update for EDURANT® (rilpivirine) to Include 96-Week Data in HIV-1-Infected Treatment-Naive Adult Patients

 Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a...


09 Nov, 2012, 17:01 ET FDA Approves New 800mg PREZISTA® (darunavir) Tablet

Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration (FDA) has approved a new 800mg...


23 Jul, 2012, 08:30 ET Award-Winning Documentary, The Other City, Returns to Washington, D.C. for AIDS 2012

Women, youth and healthcare disparities are among the HIV community topics that will be discussed at screenings of the documentary film The Other...


29 May, 2012, 09:00 ET FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet

 Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration (FDA) has issued a Complete...


24 Apr, 2012, 09:24 ET Watching, Reading and Listening: A New Way to Interact with Patient Information

 It lies within the compact folded rectangle that accompanies prescription medicines. In black and white on paper, it follows prescription...


12 Apr, 2012, 09:00 ET Janssen Therapeutics Establishes Point Scholarship for LGBT Students

Janssen Therapeutics, Division of Janssen Products, LP, is supporting education for lesbian, gay, bisexual and transgender (LGBT) students through...


27 Mar, 2012, 08:00 ET FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1, Following Priority Review

 Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved...


01 Aug, 2011, 09:00 ET Stigma Remains a Significant Barrier to Routine HIV Testing by African-American Physicians, Survey Finds

Social stigma is the largest barrier to routine HIV testing by African-American frontline care physicians, according to a survey commissioned...